|
|
||||||||
Institute for Molecular Biosciences, University of Queensland, St. Lucia, Queensland 4072, Australia
Several cystic
fibrosis (CF) mouse models demonstrate an increased susceptibility to
Pseudomonas aeruginosa lung infection, characterized by
excessive inflammation and high rates of mortality. Here we developed a
model of chronic P. aeruginosa lung disease in mice
homozygous for the murine CF transmembrane conductance regulator G551D
mutation that provides an excellent model for CF lung disease. After 3 days of infection with mucoid P. aeruginosa entrapped in
agar beads, the G551D animals lost substantially more body weight than
non-CF control animals and were less able to control the infection,
harboring over 40-fold more bacteria in the lung. The airways of
infected G551D animals contained altered concentrations of the
inflammatory mediators tumor necrosis factor-
, KC/N51, and
macrophage inflammatory protein-2 during the first 2 days of infection,
suggesting that an ineffective inflammatory response is partly
responsible for the clearance defect.
cystic fibrosis; mouse model; lung inflammation; bacterial pulmonary clearance
This article has been cited by other articles:
![]() |
I Kukavica-Ibrulj and R C Levesque Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies Lab Anim, October 1, 2008; 42(4): 389 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perez, A. M. van Heeckeren, D. Nichols, S. Gupta, J. F. Eastman, and P. B. Davis Peroxisome proliferator-activated receptor-{gamma} in cystic fibrosis lung epithelium Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L303 - L313. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Yu, S M Buff, J E Baatz, and I Virella-Lowell Oral instillation with surfactant phospholipid: a reliable alternative to intratracheal injection in mouse studies Lab Anim, July 1, 2008; 42(3): 294 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Hilliard, J. Zhu, R. Farley, S. Escudero-Garcia, B. J. Wainwright, P. K. Jeffery, U. Griesenbach, A. Bush, J. C. Davies, and E. W. F. W. Alton Nasal Abnormalities in Cystic Fibrosis Mice Independent of Infection and Inflammation Am. J. Respir. Cell Mol. Biol., July 1, 2008; 39(1): 19 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guilbault, Z. Saeed, G. P. Downey, and D. Radzioch Cystic Fibrosis Mouse Models Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. van Heeckeren, M. D. Schluchter, W. Xue, and P. B. Davis Response to Acute Lung Infection with Mucoid Pseudomonas aeruginosa in Cystic Fibrosis Mice Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 288 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Geary, H. Akinbi, T. Korfhagen, J.-E. Fabre, R. Boucher, and W. Rice Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L890 - L895. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. van Heeckeren, M. D. Schluchter, M. L. Drumm, and P. B. Davis Role of Cftr genotype in the response to chronic Pseudomonas aeruginosa lung infection in mice Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L944 - L952. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Lau, H. Ran, F. Kong, D. J. Hassett, and D. Mavrodi Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice Infect. Immun., July 1, 2004; 72(7): 4275 - 4278. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |